Atara Biotherapeutics, Inc.
ATRA· Nasdaq
Released Nov 6, 2019, after the close
10-Q filed Nov 7, 2019, 38 days after period end · 0001564590-19-041368
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Net Income | -$71.90M | -$58.36M | -$31.10M | -$25.37M |
| EPS Diluted | -$1.31 | -$1.29 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Atara Biotherapeutics, Inc. · CIK 1604464 · Engraved from SEC EDGAR